ALTAMIR (LTA) AI Stock Analysis

• Market Cap: N/A
• Dividend Yield: 3.56%
• Average Volume (3M): 925.00
• Price to Earnings (P/E): 57.1
• Beta (1Y): -0.02
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: FR
• Employees: N/A
• Sector: Financial
• Sector Strength: 70
• Industry: Asset Management
• EPS (TTM): -0.46
• Shares Outstanding: 36,512,302
• 10 Day Avg. Volume: 1,554
• 30 Day Avg. Volume: 925
• PEG Ratio: -1.30
• Price to Book (P/B): 0.64
• Price to Sales (P/S): 11.34
• P/FCF Ratio: 13.41
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 0.4
• Revenue Forecast (FY): €39.80M

• Rating: 55 Neutral
• Price Target: €30.00 ▲(1.69% Upside)

The score is primarily held back by mixed financial quality (volatile earnings and inconsistent cash generation) and a demanding valuation (high P/E). These are partly offset by a strong, low-leverage balance sheet and a mixed technical setup where longer-term trend support contrasts with weaker short-term momentum.

ALTAMIR Business Overview & Revenue Model

Company Description

Altamir SCA formerly known as Altamir Amboise, is a private equity firm specializing in both direct and fund of fund investments, small and mid-cap companies. In direct investing, the firm specializes in middle market, buyout and growth capital investments. The firm prefers to invest in under-developed divisions of larger corporations. It prefers to invest in private equity funds specializing in growth capital and leverage buyouts investments. The firm typically invests in the following sectors: healthcare, TMT, digital companies, services, retail and distribution. It also invests in retail and consumer, business and financial services. In healthcare, it seeks to focus on companies with strong growth potential in areas such as health services (hospitalization structures, home health care and medical analysis); medical devices; in niche pharmaceutical laboratories; and companies in related activities such as dermo-cosmetics, galenic development, and services and databases for health organizations. The firm seeks to invest in unlisted companies based in Europe, with a particular focus on Belgium, France, Luxembourg, Switzerland, Monaco, Italy, Netherlands, Germany and French-speaking Europe; United States and Canada and in larger emerging markets such as China, India and Brazil. In small and mid-cap companies firm prefers to invest in Continental Europe with a focus in France, Italy and Benelux, & larger size companies in Europe, North America and emerging countries like China, India and Brazil. In small and mid-cap size companies it prefers to invest with enterprise value between €50 million ($55.36 million) and €500 million ($553.6 million) and in larger size companies it prefers to invest with enterprise value between €500 million ($553.60 million) and €3000 million ($3321.62 million). It invests in funds that seek to have a majority stake in its investments or be a lead shareholder. It invests and disinvests with the private equity funds of Apax Partners France and Amboise Investissement under the same conditions and also invests directly in funds managed or advised by Apax Partners France and Apax Partners LLC. The firm seeks to exit its investments within five years. It makes balance sheet investments. Altamir SCA was founded in 1995 and is based in Paris, France.

How the Company Makes Money

ALTAMIR makes money primarily through capital appreciation and income generation from its portfolio of investments. The company invests in private equity funds managed by Apax Partners, which target high-growth potential companies. Revenue is generated when these portfolio companies are sold at a profit or through dividends and interest from investments. ALTAMIR also benefits from management fees and carried interest associated with its investments, as well as strategic partnerships with other financial institutions that enhance deal flow and investment opportunities.

ALTAMIR Financial Statement Overview

Summary

Strong balance sheet with low leverage provides resilience, and profitability rebounded to positive earnings in 2023–2024. Offsetting this, results are volatile (sharp loss in 2022), revenue growth is negative in most periods, and cash generation has been inconsistent with multiple years of negative operating/free cash flow despite improvement in 2024.

Income Statement

Profitability is strong in most years, with very high margins in 2019–2021 and a solid rebound to positive earnings in 2023–2024. However, results are volatile: 2022 shows a sharp loss, and revenue growth is negative in most periods (including 2024), suggesting an uneven top-line trajectory that can drive outsized swings in earnings.

Balance Sheet

The balance sheet looks conservatively positioned with low leverage throughout the period (debt modest relative to equity), which provides resilience in weaker years. The main drawback is muted recent profitability on the equity base (notably low returns in 2023–2024), indicating the capital base is not currently generating strong returns despite the healthy balance sheet structure.

Cash Flow

Cash generation is inconsistent. Operating and free cash flow were strongly positive in 2019 and improved meaningfully in 2024, but cash flow was negative in multiple years (2020–2023), including a particularly weak 2023. This variability reduces confidence in the durability of cash conversion despite the recent improvement.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	6.93M	72.70M	3.25M	52.52M	104.66M	157.37M
Gross Profit	-14.70M	30.20M	32.56M	39.91M	93.63M	129.10M
EBITDA	-29.44M	32.45M	34.77M	-19.15M	311.88M	191.21M
Net Income	-33.60M	18.80M	28.25M	-26.95M	291.95M	139.10M
Balance Sheet
Total Assets	1.36B	1.68B	1.41B	1.42B	1.45B	1.36B
Cash, Cash Equivalents and Short-Term Investments	62.54M	35.20M	21.60M	146.39M	188.89M	76.81M
Total Debt	44.87M	238.50M	59.01M	57.82M	26.01M	98.12M
Total Liabilities	135.52M	397.50M	112.71M	103.19M	69.09M	232.35M
Stockholders Equity	1.22B	1.28B	1.30B	1.31B	1.38B	1.13B
Cash Flow
Free Cash Flow	34.83M	61.47M	-92.80M	-28.60M	-44.99M	-66.15M
Operating Cash Flow	34.83M	61.47M	-92.80M	-28.60M	-44.99M	-66.15M
Investing Cash Flow	0.00	0.00	0.00	0.00	216.53M	0.00
Financing Cash Flow	20.00M	-53.40M	-31.29M	-37.21M	-53.99M	44.28M

ALTAMIR Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 29.50
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:LTA, the sentiment is Neutral. The current price of 29.5 is below the 20-day moving average (MA) of 29.60, below the 50-day MA of 29.84, and above the 200-day MA of 27.88, indicating a neutral trend. The MACD of -0.08 indicates Positive momentum. The RSI at 43.16 is Neutral, neither overbought nor oversold. The STOCH value of 31.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FR:LTA.

ALTAMIR Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
MF	65 Neutral	€3.70B	-41.81	-2.85%	7.66%	9.86%	-118.70%
PEUG	64 Neutral	€1.88B	45.86	0.83%	4.29%	-48.21%	-64.53%
TKO	62 Neutral	€2.80B	15.19	5.94%	5.10%	12.44%	12.15%
LTA	55 Neutral	―	57.11	―	3.56%	―	―
RF	46 Neutral	€3.34B	-5.63	-8.86%	4.99%	11.76%	-735.88%